FDA concluded that AXS-14’s New Drug Application was not sufficiently complete for substantive review, citing concerns with ...

T'puram: The new Coast Guard jetty at Vizhinjam was inaugurated by director general S Paramesh in the presence of inspector ...

In response to the FDA's feedback, Axsome plans to conduct an additional controlled trial that will use a fixed-dose paradigm ...

The FDA rejected Axsome's AXS-14 fibromyalgia, prompting a new trial and pushing the expected drug launch to 2028.

Axsome Therapeutics has hit a costly snag in its mission to bring esreboxetine to market for fibromyalgia. | Axsome ...

Investing.com -- Shares of Axsome Therapeutics Inc (NASDAQ: AXSM) fell 1.2% following the U.S. Food and Drug Administration’s (FDA) Refusal to File (RTF) letter regarding the company’s New Drug ...

Shares of Axsome Therapeutics, Inc. (AXSM) slumped 3% in the pre-market session on Monday after the company said that it has ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...

AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor for the management of fibromyalgia and other conditions. Esreboxetine, the SS-enantiomer of reboxetine, is more ...

The absence of Belarusian flag next to Aryna Sabalenka's name at the French Open has drawn attention. Instead, a plain blue ...

The newly inaugurated Coast Guard Jetty at Vizhinjam will be <br />a cutting edge in safe berthing and swift deployment of surface assets, Director General of Indian Coast Guard S Paramesh said on ...